# Ocugen (stock symbol: OCGN) Logo in transparent PNG and SVG formats

## Ocugen Logo large

### Ocugen Logo large Download PNG (59.76 KB)

![Ocugen Logo large Download PNG (59.76 KB)](/img/orig/OCGN_BIG-da0d039d.png)

### Ocugen Logo large Download SVG (6.52 KB)

![Ocugen Logo large Download SVG (6.52 KB)](/img/orig/OCGN_BIG-c3c1f5b4.svg)

## Ocugen Logo icon format

### Ocugen Logo icon format Download PNG (58.6 KB)

![Ocugen Logo icon format Download PNG (58.6 KB)](/img/orig/OCGN-87ae5839.png)

### Ocugen Logo icon format Download SVG (6.34 KB)

![Ocugen Logo icon format Download SVG (6.34 KB)](/img/orig/OCGN-c9a59e03.svg)

## Ocugen Logo large for dark backgrounds

### Ocugen Logo large for dark backgrounds Download PNG (36.3 KB)

![Ocugen Logo large for dark backgrounds Download PNG (36.3 KB)](/img/orig/OCGN_BIG.D-34f0537c.png)

### Ocugen Logo large for dark backgrounds Download SVG (6.47 KB)

![Ocugen Logo large for dark backgrounds Download SVG (6.47 KB)](/img/orig/OCGN_BIG.D-2653cb21.svg)

## Ocugen Logo icon format for dark backgrounds

### Ocugen Logo icon format for dark backgrounds Download PNG (35.62 KB)

![Ocugen Logo icon format for dark backgrounds Download PNG (35.62 KB)](/img/orig/OCGN.D-d8090eef.png)

### Ocugen Logo icon format for dark backgrounds Download SVG (6.29 KB)

![Ocugen Logo icon format for dark backgrounds Download SVG (6.29 KB)](/img/orig/OCGN.D-603fea98.svg)

## About Ocugen

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD. Ocugen, Inc. has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing; and Bharat Biotech for the commercialization of COVAXIN in the United States market. The company is headquartered in Malvern, Pennsylvania.

1. Website domain: ocugen.com
2. Employees: 56
3. Marketcap: $0.16 Billion USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
